Citadel Advisors »

Lixte Biotechnology Holdings shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lixte Biotechnology Holdings (LIXT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lixte Biotechnology Holdings

Tip: Access up to 7 years of quarterly data

All positions including Lixte Biotechnology Holdings held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lixte Biotechnology Holdings by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $55k 14k 3.93
2025-03-31 $30k 25k 1.21

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Lixte Biotechnology Holdings

Scotia Capital
Renaissance Technologies
Federation des caisses Desjardins du Quebec
Vanguard Group
DRW Holdings
Geode Capital Management
Ethos Financial Group
State Street Corporation
Two Sigma Investments
XTX Topco
Citadel Advisors
Atlas Legacy Advisors
UBS Group
SBI Securities

View all funds holding Lixte Biotechnology Holdings